Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.

Jiang, Liwei; Wang, Yi-Jun; Zhao, Jing; Uehara, Mayuko; Hou, Qingming; Kasinath, Vivek; Ichimura, Takaharu; Banouni, Naima; Dai, Li; Li, Xiaofei; Greiner, Dale L; Shultz, Leonard D; Zhang, Xiaolong; Sun, Zhen-Yu Jim; Curtin, Ian; Vangos, Nicholas E; Yeoh, Zoe C; Geffken, Ezekiel A; Seo, Hyuk-Soo; Liu, Ze-Xian; Heffron, Gregory J; Shah, Khalid; Dhe-Paganon, Sirano; Abdi, Reza.

Cell ; 183(5): 1219-1233.e18, 2020 11 25.

Artigo em Inglês | MEDLINE | ID: mdl-33242418

2.

Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus.

Mineo, Marco; Lyons, Shawn M; Zdioruk, Mykola; von Spreckelsen, Niklas; Ferrer-Luna, Ruben; Ito, Hirotaka; Alayo, Quazim A; Kharel, Prakash; Giantini Larsen, Alexandra; Fan, William Y; Auduong, Sophia; Grauwet, Korneel; Passaro, Carmela; Khalsa, Jasneet K; Shah, Khalid; Reardon, David A; Ligon, Keith L; Beroukhim, Rameen; Nakashima, Hiroshi; Ivanov, Pavel; Anderson, Paul J; Lawler, Sean E; Chiocca, E Antonio.

Mol Cell ; 78(6): 1207-1223.e8, 2020 06 18.

Artigo em Inglês | MEDLINE | ID: mdl-32504554

3.

Using System Dynamics Approach to Explore the Mode Shift between Automated Vehicles, Conventional Vehicles, and Public Transport in Melbourne, Australia.

Chen, Yilun; Stasinopoulos, Peter; Shiwakoti, Nirajan; Khan, Shah Khalid.

Sensors (Basel) ; 23(17)2023 Aug 24.

Artigo em Inglês | MEDLINE | ID: mdl-37687841

4.

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma.

Ishii, Yuki; Kolluri, Krishna K; Pennycuick, Adam; Zhang, Xidan; Nigro, Ersilia; Alrifai, Doraid; Borg, Elaine; Falzon, Mary; Shah, Khalid; Kumar, Neelam; Janes, Sam M.

J Biol Chem ; 297(5): 101223, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-34597666

5.

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.

Song, Na; Wakimoto, Hiroaki; Rossignoli, Filippo; Bhere, Deepak; Ciccocioppo, Rachele; Chen, Kok-Siong; Khalsa, Jasneet Kaur; Mastrolia, Ilenia; Samarelli, Anna Valeria; Dominici, Massimo; Shah, Khalid.

Stem Cells ; 39(6): 707-722, 2021 06.

Artigo em Inglês | MEDLINE | ID: mdl-33586320

6.

Engineered stem cells targeting multiple cell surface receptors in tumors.

Kavari, Sanam L; Shah, Khalid.

Stem Cells ; 38(1): 34-44, 2020 01.

Artigo em Inglês | MEDLINE | ID: mdl-31381835

7.

Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas.

Choi, Sung Hugh; Tamura, Kaoru; Khajuria, Rajiv Kumar; Bhere, Deepak; Nesterenko, Irina; Lawler, Jack; Shah, Khalid.

Mol Ther ; 32(5): 1595, 2024 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-38702134

8.

Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas.

Choi, Sung Hugh; Tamura, Kaoru; Khajuria, Rajiv Kumar; Bhere, Deepak; Nesterenko, Irina; Lawler, Jack; Shah, Khalid.

Mol Ther ; 2024 May 05.

Artigo em Inglês | MEDLINE | ID: mdl-38710183

9.

Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.

Du, Wanlu; Seah, Ivan; Bougazzoul, Oumaima; Choi, GiHun; Meeth, Katrina; Bosenberg, Marcus W; Wakimoto, Hiroaki; Fisher, David; Shah, Khalid.

Proc Natl Acad Sci U S A ; 114(30): E6157-E6165, 2017 07 25.

Artigo em Inglês | MEDLINE | ID: mdl-28710334

10.

Taming CAR T cell therapy toxicity.

Liu, Chuang; Shah, Khalid.

Nat Mater ; 22(12): 1444-1445, 2023 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-38036624

11.

Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies.

Bhere, Deepak; Khajuria, Rajiv Kumar; Hendriks, William T; Bandyopadhyay, Antara; Bagci-Onder, Tugba; Shah, Khalid.

Stem Cells ; 36(6): 932-942, 2018 06.

Artigo em Inglês | MEDLINE | ID: mdl-29451340

12.

Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.

Jahan, Nusrat; Lee, Jae M; Shah, Khalid; Wakimoto, Hiroaki.

Int J Cancer ; 141(8): 1671-1681, 2017 10 15.

Artigo em Inglês | MEDLINE | ID: mdl-28567859

13.

Measuring impact of telephone triage in Acute Medicine.

Asmat, Huma; Shinwari, Shah Khalid; Cooksley, Tim; Duckitt, Roger; Le Jeune, Ivan; Subbe, Christian P.

Acute Med ; 16(3): 104-106, 2017.

Artigo em Inglês | MEDLINE | ID: mdl-29072867

14.

Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.

Redjal, Navid; Zhu, Yanni; Shah, Khalid.

Stem Cells ; 33(1): 101-10, 2015 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-25186100

15.

Engineering toxin-resistant therapeutic stem cells to treat brain tumors.

Stuckey, Daniel W; Hingtgen, Shawn D; Karakas, Nihal; Rich, Benjamin E; Shah, Khalid.

Stem Cells ; 33(2): 589-600, 2015 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-25346520

16.

Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.

Bagci-Onder, Tugba; Du, Wanlu; Figueiredo, Jose-Luiz; Martinez-Quintanilla, Jordi; Shah, Khalid.

Brain ; 138(Pt 6): 1710-21, 2015 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-25910782

17.

Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.

Martinez-Quintanilla, Jordi; He, Derek; Wakimoto, Hiroaki; Alemany, Ramon; Shah, Khalid.

Mol Ther ; 23(1): 108-18, 2015 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-25352242

18.

Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas.

Choi, Sung Hugh; Tamura, Kaoru; Khajuria, Rajiv Kumar; Bhere, Deepak; Nesterenko, Irina; Lawler, Jack; Shah, Khalid.

Mol Ther ; 23(2): 235-43, 2015 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-25358253

19.

Multifunctional receptor-targeting antibodies for cancer therapy.

Zhu, Yanni; Choi, Sung Hugh; Shah, Khalid.

Lancet Oncol ; 16(15): e543-e554, 2015 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-26545843

20.

Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.

van de Water, Jeroen A J M; Bagci-Onder, Tugba; Agarwal, Aayush S; Wakimoto, Hiroaki; Roovers, Rob C; Zhu, Yanni; Kasmieh, Randa; Bhere, Deepak; Van Bergen en Henegouwen, Paul M P; Shah, Khalid.

Proc Natl Acad Sci U S A ; 109(41): 16642-7, 2012 Oct 09.

Artigo em Inglês | MEDLINE | ID: mdl-23012408

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.

Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus.

Using System Dynamics Approach to Explore the Mode Shift between Automated Vehicles, Conventional Vehicles, and Public Transport in Melbourne, Australia.

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma.

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.

Engineered stem cells targeting multiple cell surface receptors in tumors.

Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas.

Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas.

Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.

Taming CAR T cell therapy toxicity.

Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies.

Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.

Measuring impact of telephone triage in Acute Medicine.

Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.

Engineering toxin-resistant therapeutic stem cells to treat brain tumors.

Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.

Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.

Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas.

Multifunctional receptor-targeting antibodies for cancer therapy.

Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects.